Death Due to COVID-19 in an Infant with Combined Immunodeficiencies

Title:Death Due to COVID-19 in an Infant with Combined Immunodeficiencies

Volume: 21 Issue: 9

Author(s): Hamid Ahanchian, Nasrin Moazzen*, Amin Saeidinia, Seyed H. Joghatayi, Maryam Khoshkhui, Mohammad H. Aelami, Nasrin S. M. Haghi and Nima Rezaei*

Affiliation:

• Allergy Research Center, Mashhad University of Medical Sciences, Mashhad,Iran

• Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran,Iran

Keywords: Combined immunodeficiency, COVID-19, cardiac injury, infant, death, bone marroow.

Abstract:

Background: Severe Acute Respiratory Syndrome Coronavirus 2 has affected millions of people, and especially in adult patients with underlying diseases lead to death. Meanwhile pediatric patients with inherited defects of T cell should be prone to viral diseases.

Case Presentation: Herein, we report an infant with severe combined immunodeficiencies, who were affected and died because of COVID-19.

Conclusion: Considering the importance of finding how immune system can affect the viral infection, presentation of COVID-19 in immune deficient patients can be valuable.

Cite this article as:

Ahanchian Hamid , Moazzen Nasrin *, Saeidinia Amin , Joghatayi H. Seyed , Khoshkhui Maryam , Aelami H. Mohammad , Haghi S. M. Nasrin and Rezaei Nima *, Death Due to COVID-19 in an Infant with Combined Immunodeficiencies, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (9) . https://dx.doi.org/10.2174/1871530320666201021142313